As of 11th March 2015, a Phase II clinical trial of a potential Ebola treatment is underway in Sierra Leone. The trial of the therapy, TKM-Ebola-Guinea, is being led by Professor Peter Horby. TKM-Ebola-Guinea is a synthetic small interfering RNA therapeutic designed specifically to target the strain of the Ebola virus responsible for the present outbreak in Guinea, Liberia and Sierra Leone.
Ebola research in NDM
12 March 2015